Serum glial cell line-derived neurotrophic factor (sgdnf) is a novel biomarker in predicting cirrhosis in patients with chronic hepatitis b

HIGHLIGHTS

  • who: Hepatitis B and colleagues from the Laboratory of Liver Disease, Department of Infectious Disease, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China have published the article: Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B, in the Journal: Canadian Journal of Gastroenterology and Hepatology of 22/05/2022
  • what: The authors assessed GDNF along with biochemical and histological parameters of liver disease in CHB patients.
  • how: Oneway analysis of variance (ANOVA) was used for the comparison of multiple . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?